DEUTSCHE BANK AG\ - THERAVANCE BIOPHARMA INC ownership

Back to all holdings Add to watchlist

THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is 88339KAA0. A total of 20 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.6%.

Links
Filings
Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q2 2020$1,042,000
-26.5%
1,082,000
-26.7%
0.00%0.0%
Q1 2020$1,417,000
+15.3%
1,476,000
+19.0%
0.00%–
Q2 2018$1,229,000
-36.7%
1,240,000
-13.9%
0.00%
-100.0%
Q2 2017$1,943,000–1,440,000–0.00%–
 Download
Other shareholders

There were no reported owners of THERAVANCE BIOPHARMA INC in Q2 2018.

NameSharesValueWeighting ↓
View complete list of THERAVANCE BIOPHARMA INC shareholders